Intra-Arterial Tenecteplase After Thrombectomy: Promising but Inconclusive
Ashutosh Jadhav recently shared a post on further management of stroke after successful thrombectomy on X:
”Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy.”
Read the full JAMA article here.
A recent study evaluating intra-arterial tenecteplase administered after successful thrombectomy in patients with acute large vessel occlusion (LVO) presenting between 4.5 and 24 hours of symptom onset has shown encouraging yet inconclusive results.
Patients receiving intra-arterial tenecteplase demonstrated a greater likelihood of excellent neurological outcomes at 90 days, without an associated increase in symptomatic intracranial hemorrhage (sICH) or mortality.
However, the optimism was tempered by the fact that none of the secondary efficacy endpoints reinforced the primary findings.
The authors emphasized that further trials are necessary to validate these results and better define the role of intra-arterial tenecteplase in extended-window stroke management.
More on advancements in stroke management featured in Hemostasis Today.
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation